Estrella Immunopharma Names Cynthia Pussinen CEO and Board Chairperson

• Estrella Immunopharma appointed Cynthia Pussinen CEO and board chair, effective October 25, 2026.
• Pussinen previously served as managing director, biotech investments, at Sorbie Bornholm and CEO of Sernova.
• She succeeds Cheng Liu as CEO; Liu was appointed chief scientific officer.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Estrella Immunopharma Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610260800BIZWIRE_USPR_____20261026_BW021449) on October 26, 2026, and is solely responsible for the information contained therein.